Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.

Azad NS, Gray RJ, Overman MJ, Schoenfeld JD, Mitchell EP, Zwiebel JA, Sharon E, Streicher H, Li S, McShane LM, Rubinstein L, Patton DR, Williams PM, Coffey B, Hamilton SR, Bahary N, Suga JM, Hatoum H, Abrams JS, Conley BA, Arteaga CL, Harris L, O'Dwyer PJ, Chen AP, Flaherty KT.

J Clin Oncol. 2019 Nov 25:JCO1900818. doi: 10.1200/JCO.19.00818. [Epub ahead of print]

PMID:
31765263
2.

Evaluation of fertigation management impacts of surface drip irrigation on reducing nitrate leaching using numerical modeling.

Azad N, Behmanesh J, Rezaverdinejad V, Abbasi F, Navabian M.

Environ Sci Pollut Res Int. 2019 Nov 15. doi: 10.1007/s11356-019-06699-2. [Epub ahead of print]

PMID:
31732949
3.

Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades.

Sawas T, Azad N, Killcoyne S, Iyer PG, Wang KK, Fitzgerald RC, Katzka DA.

Clin Gastroenterol Hepatol. 2019 Nov 8. pii: S1542-3565(19)31269-8. doi: 10.1016/j.cgh.2019.11.014. [Epub ahead of print]

PMID:
31712077
4.

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.

Yarchoan M, Mohan AA, Dennison L, Vithayathil T, Ruggieri A, Lesinski GB, Armstrong TD, Azad NS, Jaffee EM.

PLoS One. 2019 Oct 31;14(10):e0224600. doi: 10.1371/journal.pone.0224600. eCollection 2019.

5.

Hyperthermia versus busulfan: Finding the effective method in animal model of azoospermia induction.

Ziaeipour S, Rezaei F, Piryaei A, Abdi S, Moradi A, Ghasemi A, Azad N, Abdollahifar MA.

Andrologia. 2019 Dec;51(11):e13438. doi: 10.1111/and.13438. Epub 2019 Oct 3.

PMID:
31583731
6.

Calcium signaling and salt tolerance are diversely entwined in plants.

Seifikalhor M, Aliniaeifard S, Shomali A, Azad N, Hassani B, Lastochkina O, Li T.

Plant Signal Behav. 2019;14(11):1665455. doi: 10.1080/15592324.2019.1665455. Epub 2019 Sep 28.

PMID:
31564206
7.

Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT).

Agrawal L, Azad N, Bahn GD, Reaven PD, Hayward RA, Reda DJ, Emanuele NV; VADT Study Group.

Diabetes Care. 2019 Nov;42(11):e181-e182. doi: 10.2337/dc19-0891. Epub 2019 Sep 23. No abstract available.

PMID:
31548245
8.

Equity and diversity in academic medicine: a perspective from the JCI editors.

Resar LM, Jaffee EM, Armanios M, Jackson S, Azad NS, Horton MR, Kaplan MJ, Laiho M, Maus MV, Sumner CJ, Wheelan SJ, Wills-Karp M.

J Clin Invest. 2019 Oct 1;129(10):3974-3977. doi: 10.1172/JCI130902. No abstract available.

9.

Ulmus minor bark hydro-alcoholic extract ameliorates histological parameters and testosterone level in an experimental model of PCOS rats.

Hoseinpour MJ, Ghanbari A, Azad N, Zare A, Abdi S, Sajadi E, Abbaszadeh HA, Farahani RM, Abdollahifar MA.

Endocr Regul. 2019 Jul 1;53(3):146-153. doi: 10.2478/enr-2019-0015.

PMID:
31517633
10.

An analysis of genetic heterogeneity in untreated cancers.

Reiter JG, Baretti M, Gerold JM, Makohon-Moore AP, Daud A, Iacobuzio-Donahue CA, Azad NS, Kinzler KW, Nowak MA, Vogelstein B.

Nat Rev Cancer. 2019 Nov;19(11):639-650. doi: 10.1038/s41568-019-0185-x. Epub 2019 Aug 27.

PMID:
31455892
11.

Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer.

Russo S, Anker CJ, Abdel-Wahab M, Azad N, Das P, Dragovic J, Goodman KA, Herman JM, Jones W 3rd, Kennedy T, Konski A, Kumar R, Lee P, Patel NM, Sharma N, Small W, Suh WW, Jabbour SK; Expert Panel on Radiation Oncology- Local Excision in Rectal Cancer.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):977-993. doi: 10.1016/j.ijrobp.2019.08.020. Epub 2019 Aug 22. Review.

PMID:
31445109
12.

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.

Jia AY, Narang A, Safar B, Zaheer A, Murphy A, Azad NS, Gearhart S, Fang S, Efron J, Warczynski T, Hacker-Prietz A, Meyer J.

Radiat Oncol. 2019 Aug 19;14(1):147. doi: 10.1186/s13014-019-1358-1.

13.

Vitamin C restores ovarian follicular reservation in a mouse model of aging.

Abdollahifar MA, Azad N, Sajadi E, Shams Mofarahe Z, Zare F, Moradi A, Rezaee F, Gholamin M, Abdi S.

Anat Cell Biol. 2019 Jun;52(2):196-203. doi: 10.5115/acb.2019.52.2.196. Epub 2019 Jun 30.

14.

Precision Cancer Trials With Immunomodulatory Agents: Personalizing Histology Agnostic Approaches.

Baretti M, Azad NS.

Cancer J. 2019 Jul/Aug;25(4):287-295. doi: 10.1097/PPO.0000000000000390.

PMID:
31335393
15.

Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.

Lowery MA, Burris HA 3rd, Janku F, Shroff RT, Cleary JM, Azad NS, Goyal L, Maher EA, Gore L, Hollebecque A, Beeram M, Trent JC, Jiang L, Fan B, Aguado-Fraile E, Choe S, Wu B, Gliser C, Agresta SV, Pandya SS, Zhu AX, Abou-Alfa GK.

Lancet Gastroenterol Hepatol. 2019 Sep;4(9):711-720. doi: 10.1016/S2468-1253(19)30189-X. Epub 2019 Jul 9.

PMID:
31300360
16.

Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer.

Russo S, Anker CJ, Abdel-Wahab M, Azad N, Bianchi N, Das P, Dragovic J, Goodman KA, Jones W 3rd, Kennedy T, Kumar R, Lee P, Sharma N, Small W, Suh WW, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):591-605. doi: 10.1016/j.ijrobp.2019.06.2544. Epub 2019 Jul 6. Review. No abstract available.

PMID:
31288054
17.

Readmission Adversely Affects Survival in Surgical Rectal Cancer Patients.

Chen SY, Stem M, Gearhart SL, Safar B, Fang SH, Azad NS, Murphy AG, Narang AK, Wolfgang CL, Efron JE.

World J Surg. 2019 Oct;43(10):2506-2517. doi: 10.1007/s00268-019-05053-4.

PMID:
31222644
18.

A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers.

Kurzrock R, Ball DW, Zahurak ML, Nelkin BD, Subbiah V, Ahmed S, O'Connor A, Karunsena E, Parkinson RM, Bishop JA, Ha Y, Sharma R, Gocke CD, Zinner R, Rudek MA, Sherman SI, Azad NS.

Clin Cancer Res. 2019 Sep 15;25(18):5475-5484. doi: 10.1158/1078-0432.CCR-18-1881. Epub 2019 Jun 11.

PMID:
31186313
19.

Opportunities for Care Optimization and Hospitalization Reduction for Older Persons With Heart Failure.

Azad N.

Clin Med Insights Cardiol. 2019 May 6;13:1179546819841597. doi: 10.1177/1179546819841597. eCollection 2019. No abstract available.

20.

The DNA Damaging Revolution: PARP Inhibitors and Beyond.

Yap TA, Plummer R, Azad NS, Helleday T.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:185-195. doi: 10.1200/EDBK_238473. Epub 2019 May 17. Review.

21.

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival.

Danilova L, Ho WJ, Zhu Q, Vithayathil T, De Jesus-Acosta A, Azad NS, Laheru DA, Fertig EJ, Anders R, Jaffee EM, Yarchoan M.

Cancer Immunol Res. 2019 Jun;7(6):886-895. doi: 10.1158/2326-6066.CIR-18-0822. Epub 2019 May 1.

PMID:
31043417
22.

A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.

Gaillard SL, Zahurak M, Sharma A, Durham JN, Reiss KA, Sartorius-Mergenthaler S, Downs M, Anders NM, Ahuja N, Rudek MA, Azad N.

Cancer. 2019 Aug 15;125(16):2837-2845. doi: 10.1002/cncr.32138. Epub 2019 Apr 23.

PMID:
31012962
23.

The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells.

Yakisich JS, Azad N, Kaushik V, Iyer AKV.

Stem Cells Int. 2019 Feb 21;2019:6254269. doi: 10.1155/2019/6254269. eCollection 2019.

24.

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers.

Yarchoan M, Albacker LA, Hopkins AC, Montesion M, Murugesan K, Vithayathil TT, Zaidi N, Azad NS, Laheru DA, Frampton GM, Jaffee EM.

JCI Insight. 2019 Mar 21;4(6). pii: 126908. doi: 10.1172/jci.insight.126908. eCollection 2019 Mar 21.

25.

Effect of Artificial Oocyte Activation on Intra-Cytoplasmic Sperm Injection Outcomes in Patients with Lower Percentage of Sperm Containing Phospholipase Cζ: A Randomized Clinical Trial.

Nazarian H, Azad N, Nazari L, Piryaei A, Heidari MH, Masteri-Farahani R, Karimi M, Ghaffari-Novin M.

J Reprod Infertil. 2019 Jan-Mar;20(1):3-9.

26.

Contextual Factors Associated With Quality Improvement Success in a Multisite Ambulatory Setting.

Douglas LC, Heo M, Azad N, Racine AD, Rinke ML.

J Healthc Qual. 2019 Sep/Oct;41(5):317-328. doi: 10.1097/JHQ.0000000000000186.

PMID:
30730399
27.

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.

Christmas BJ, Rafie CI, Hopkins AC, Scott BA, Ma HS, Cruz KA, Woolman S, Armstrong TD, Connolly RM, Azad NA, Jaffee EM, Roussos Torres ET.

Cancer Immunol Res. 2018 Dec;6(12):1561-1577. doi: 10.1158/2326-6066.CIR-18-0070. Epub 2018 Oct 19.

28.

Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Goff LW, Azad NS, Stein S, Whisenant JG, Koyama T, Vaishampayan U, Hochster H, Connolly R, Weise A, LoRusso PM, Salaria SN, El-Rifai W, Berlin JD.

Invest New Drugs. 2018 Dec;36(6):1158. doi: 10.1007/s10637-018-0679-5.

PMID:
30334109
29.

Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Kaushik V, Yakisich JS, Kumar A, Azad N, Iyer AKV.

Cancers (Basel). 2018 Sep 27;10(10). pii: E360. doi: 10.3390/cancers10100360. Review.

30.

Chemoresistance of cancer floating cells is independent of their ability to form 3D structures: Implications for anticancer drug screening.

Kaushik V, Yakisich JS, Way LF, Azad N, Iyer AKV.

J Cell Physiol. 2019 Apr;234(4):4445-4453. doi: 10.1002/jcp.27239. Epub 2018 Sep 7.

PMID:
30191978
31.

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Goff LW, Azad NS, Stein S, Whisenant JG, Koyama T, Vaishampayan U, Hochster H, Connolly R, Weise A, LoRusso PM, Salaria SN, El-Rifai W, Berlin JD.

Invest New Drugs. 2019 Apr;37(2):315-322. doi: 10.1007/s10637-018-0663-0. Epub 2018 Sep 6. Erratum in: Invest New Drugs. 2018 Oct 18;:.

PMID:
30191522
32.

A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan.

Lee V, Wang J, Zahurak M, Gootjes E, Verheul HM, Parkinson R, Kerner Z, Sharma A, Rosner G, De Jesus-Acosta A, Laheru D, Le DT, Oganesian A, Lilly E, Brown T, Jones P, Baylin S, Ahuja N, Azad N.

Clin Cancer Res. 2018 Dec 15;24(24):6160-6167. doi: 10.1158/1078-0432.CCR-18-0421. Epub 2018 Aug 10.

PMID:
30097434
33.

Real-time quantitative PCR: a reliable molecular diagnostic and follow-up tool for 'minimal residual disease' assessment in chronic myeloid leukemia.

Azad NA, Shah ZA, Pandith AA, Rasool R, Jeelani S.

Biosci Rep. 2018 Oct 5;38(5). pii: BSR20180974. doi: 10.1042/BSR20180974. Print 2018 Oct 31.

34.

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.

Overman MJ, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic TR, Azad N, Kopetz S.

Ann Oncol. 2019 Mar 1;30(3):495. doi: 10.1093/annonc/mdy221. No abstract available.

35.

Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir

Azad NA, Shah ZA, Pandith AA, Khan MS, Rasool R, Rasool J, Aziz SA.

Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1479-1485.

36.

Candidate Enzymes for Saffron Crocin Biosynthesis Are Localized in Multiple Cellular Compartments.

Demurtas OC, Frusciante S, Ferrante P, Diretto G, Azad NH, Pietrella M, Aprea G, Taddei AR, Romano E, Mi J, Al-Babili S, Frigerio L, Giuliano G.

Plant Physiol. 2018 Jul;177(3):990-1006. doi: 10.1104/pp.17.01815. Epub 2018 May 29.

37.

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease.

Boyiadzis MM, Kirkwood JM, Marshall JL, Pritchard CC, Azad NS, Gulley JL.

J Immunother Cancer. 2018 May 14;6(1):35. doi: 10.1186/s40425-018-0342-x. Review.

38.

The role of epigenetic therapies in colorectal cancer.

Baretti M, Azad NS.

Curr Probl Cancer. 2018 Nov;42(6):530-547. doi: 10.1016/j.currproblcancer.2018.03.001. Epub 2018 Mar 12. Review.

PMID:
29625794
39.

Perioperative Cardiac Risk Assessment for the Frail Older Adult.

Whitney K, Azad N, Power B.

Can J Cardiol. 2018 Mar;34(3):343.e11. doi: 10.1016/j.cjca.2017.12.002. Epub 2017 Dec 7. No abstract available.

PMID:
29475538
40.

Evaluation of PAWP and PLC? Expression in Infertile Men with Previous ICSI Fertilization Failure.

Azad N, Nazarian H, Nazari L, Ghaffari Novin M, Piryaei A, Heidari MH, Masteri Farahani R, Sadjadpour SS.

Urol J. 2018 May 3;15(3):116-121. doi: 10.22037/uj.v0i0.3966.

41.

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Shroff RT, Yarchoan M, O'Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Parkinson R, Subbiah V, Zinner R, Azad NS.

Br J Cancer. 2018 Jan;118(2):e2. doi: 10.1038/bjc.2017.418. Epub 2018 Jan 9. No abstract available.

42.

A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis.

Kulkarni YM, Dutta S, Iyer AKV, Wright CA, Ramesh V, Kaushik V, Semmes OJ, Azad N.

Proteomics Clin Appl. 2018 May;12(3):e1700086. doi: 10.1002/prca.201700086. Epub 2018 Jan 19.

43.

Selective and Irreversible Induction of Necroptotic Cell Death in Lung Tumorspheres by Short-Term Exposure to Verapamil in Combination with Sorafenib.

Yakisich JS, Kulkarni Y, Azad N, Iyer AKV.

Stem Cells Int. 2017;2017:5987015. doi: 10.1155/2017/5987015. Epub 2017 Oct 19.

44.

In vitro development of embryos from experimentally Kerack-addicted Mice.

Mohammadzadeh E, Amjadi FS, Movahedin M, Zandieh Z, Nazmara Z, Eslahi N, Shirinbayan P, Asgari HR, Azad N, Salimi M, Koruji M.

Int J Reprod Biomed (Yazd). 2017 Jul;15(7):413-422.

45.

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).

Agrawal L, Azad N, Bahn GD, Ge L, Reaven PD, Hayward RA, Reda DJ, Emanuele NV; VADT Study Group.

Diabetologia. 2018 Feb;61(2):295-299. doi: 10.1007/s00125-017-4473-2. Epub 2017 Nov 3.

46.

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.

Overman MJ, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic R 2nd, Azad N, Kopetz S.

Ann Oncol. 2018 Jan 1;29(1):139-144. doi: 10.1093/annonc/mdx688. Erratum in: Ann Oncol. 2019 Mar 1;30(3):495.

47.

Translational gap in ongoing clinical trials for glioma.

Guishard AF, Yakisich JS, Azad N, Iyer AKV.

J Clin Neurosci. 2018 Jan;47:28-42. doi: 10.1016/j.jocn.2017.10.001. Epub 2017 Oct 21. Review.

48.

Leadership and Management Are One and the Same.

Azad N, Anderson HG Jr, Brooks A, Garza O, O'Neil C, Stutz MM, Sobotka JL.

Am J Pharm Educ. 2017 Aug;81(6):102. doi: 10.5688/ajpe816102.

49.

Phospholipase C zeta parameters in sperm from polymorphic teratozoospermic men.

Azad N, Nazarian H, Ghaffari Novin M, Masteri Farahani R, Piryaei A, Heidari MH.

Ann Anat. 2018 Jan;215:63-70. doi: 10.1016/j.aanat.2017.09.007. Epub 2017 Sep 24.

PMID:
28954206
50.

Oligoasthenoteratozoospermic (OAT) men display altered phospholipase C ζ (PLCζ) localization and a lower percentage of sperm cells expressing PLCζ and post-acrosomal sheath WW domain-binding protein (PAWP).

Azad N, Nazarian H, Ghaffari Novin M, Masteri Farahani R, Piryaei A, Heidari MH, Abdollahpour Alitappeh M.

Bosn J Basic Med Sci. 2018 May 20;18(2):178-184. doi: 10.17305/bjbms.2017.2208.

Supplemental Content

Support Center